AstraZeneca should know by year-end whether vaccine works if trials restart

AstraZeneca should still know before the end of the year whether its experimental vaccine protects people against Covid-19, the drugmaker's chief executive Pascal Soriot said on Thursday, as long as it can resume trials soon.